Research Article
Antimicrobial-Induced Cytopenia and Bone Marrow Hypocellularity in Patients with Cirrhosis
Table 3
Cytopenias among those who received antimicrobials and those who did not (Total
).
| Antimicrobial agent | Parameter | Those who received | Those who did not receive | OR (95% CI) | value |
| Cephalosporins () | Anemia | 53.5% | 38.2% | 1.91 (0.073–3.409) | 0.128 | Leucopenia | 36% | 33.6% | 1.08 (0.597–1.957) | 0.796 | Thrombocytopenia | 58.1% | 58.2% | 1.00 (0.565–1.775) | 0.995 |
| Carbapenems () | Anemia | 50% | 43.6% | 1.294 (0.645–2.595) | 0.468 | Leucopenia | 27.5% | 36.5% | 0.659 (0.306–1.418) | 0.286 | Thrombocytopenia | 57.5% | 58.3% | 0.966 (0.478–1.952) | 0.924 |
| Beta-lactams () | Anemia | 56% | 43.3% | 1.667 (0.716–3.886) | 0.236 | Leucopenia | 40% | 33.9% | 1.299 (0.549–3.071) | 0.551 | Thrombocytopenia | 68% | 36.7% | 1.621 (1.464–2.960) | 0.041 |
| Quinolones () | Anemia | 53.8% | 44.3% | 1.469 (0.475–4.542) | 0.504 | Leucopenia | 30.8% | 35% | 0.826 (0.245–2.789) | 0.759 | Thrombocytopenia | 76.9% | 46.8% | 1.532 (1.474–2.507) | 0.039 |
| Antifungals () | Anemia | 57.9% | 43.5% | 1.786 (0.685–4.654) | 0.236 | Leucopenia | 31.6% | 35% | 0.856 (0.310–2.363) | 0.764 | Thrombocytopenia | 57.9% | 58.2% | 0.988 (0.379–2.576) | 0.980 |
|
|